Table 3 Clinicopathologic features of RGC according to reconstruction method
Variables | RGC-B I (n = 13) | RGC-B II (n = 35) | p value† | OR | 95% CI for OR | p value‡ |
|---|---|---|---|---|---|---|
Interval (years) | ||||||
< 5 | 5 (38.5%) | 10 (28.6%) | 0.024 | 1 | - | - |
≥ 5, < 10 | 7 (53.8%) | 8 (22.9%) | 0.571 | 0.130~2.503 | 0.458 | |
≥ 10 | 1 (7.7%) | 17 (48.6%) | 8.500 | 0.865~83.493 | 0.066 | |
Recurrence site | ||||||
Non-anastomosis | 11 (84.6%) | 10 (28.6%) | 0.001 | 1 | - | - |
Anastomosis | 2 (15.4%) | 25 (71.4%) | 13.750 | 2.574~73.455 | 0.002 | |
Differentiation | ||||||
Differentiated | 6 (46.2%) | 15 (42.9%) | 0.838 | 1 | - | - |
Undifferentiated | 7 (53.8%) | 20 (57.1%) | 1.143 | 0.314~4.109 | 0.838 | |
Previous cancer stage | ||||||
Stage I | 11 (84.6%) | 19 (54.3%) | 0.151 | 1 | - | - |
Stage II | 1 (7.7%) | 10 (28.6%) | 5.789 | 0.651~51.505 | 0.115 | |
Stage III | 1 (7.7%) | 6 (17.1%) | 3.272 | 0.369~32.743 | 0.277 | |
Previous PRM (cm) | ||||||
< 3 | 3 (23.1%) | 6 (17.1%) | 0.687 | 1 | - | - |
≥ 3 | 10 (76.9%) | 29 (82.9%) | 1.450 | 0.304~6.909 | 0.641 | |
Total | 6.4 ± 3.6 | 5.7 ± 3.9 | 0.580 | |||
Previous LI | ||||||
Positive | 3 (23.1%) | 14 (40.0%) | 0.330 | 2.222 | 0.518~9.537 | 0.283 |
Negative | 10 (76.9%) | 21 (60.0%) | 1 | - | - | |
Previous VI | ||||||
Positive | 1 (7.7%) | 2 (5.7%) | 1.000 | 0.727 | 0.060~8.769 | 0.802 |
Negative | 12 (92.3%) | 33 (94.3%) | 1 | - | - | |
Lauren classification | ||||||
Intestinal | 4 (30.8%) | 13 (37.1%) | 0.904 | 1 | - | - |
Diffuse | 5 (38.5%) | 13 (37.1%) | 0.800 | 0.174~3.669 | 0.774 | |
Mixed | 4 (30.8%) | 9 (25.7%) | 0.692 | 0.136~3.518 | 0.658 |